NHL, Adult
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| APG-1252 Monotherapy or in Combination With Other Therapeutic Agent in Subjects With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT05186012) | Ascentage Pharma Group Inc. | 2022-06-14 |
Track NHL, Adult automatically
Every clearance here is in the API, with alerts when new ones post.